Daewoong Pharmaceutical Co., Ltd (KRX:069620)
140,600
-1,600 (-1.13%)
At close: Nov 5, 2025
Daewoong Pharmaceutical Market Cap
Daewoong Pharmaceutical has a market cap or net worth of 1.62 trillion as of November 5, 2025. Its market cap has decreased by -1.82% in one year.
Market Cap
1.62T
Enterprise Value
2.34T
Revenue
1.49T
Ranking
n/a
PE Ratio
21.54
Stock Price
140,600.00
Market Cap Chart
Since March 12, 2003, Daewoong Pharmaceutical's market cap has increased from 131.88B to 1.62T, an increase of 1,126.72%. That is a compound annual growth rate of 11.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 1.62T | 11.23% |
| Dec 30, 2024 | 1.45T | 8.22% |
| Dec 28, 2023 | 1.34T | -23.40% |
| Dec 29, 2022 | 1.75T | 7.09% |
| Dec 30, 2021 | 1.64T | -7.75% |
| Dec 30, 2020 | 1.78T | 25.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.84T |
| ALTEOGEN | 28.29T |
| SK Biopharmaceuticals | 9.44T |
| Yuhan | 8.71T |
| HLB Co., Ltd. | 7.03T |
| ABL Bio | 6.13T |
| Peptron | 6.11T |